Furthermore, our drug response prediction analysis identified several chemotherapeutic agents, including Nutlin‐3a, Dactolisib and Rapamycin, potentially more effective in STAD tumours with high IGFBP7 expression. The gene discussed is IGFBP7; the disease is gastric adenocarcinoma.